Suchergebnisse - "Seror, Raphaele"

PubPharm (7)

1

Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent waves

enthalten in: Joint bone spine | 2023

von Drumez, E. | Richez, C. | Bebear, L. | +21

2

Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR) : a consensual composite score for assessing treatment effect in primary Sjögren's syndrome

enthalten in: Annals of the rheumatic diseases | 2022

von Seror, R. | Baron, G. | Camus, M. | +53

3

Rituximab Impairs B Cell Response But Not T Cell Response to COVID-19 Vaccine in Autoimmune Diseases

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2022

von Bitoun, S. | Henry, J. | Desjardins, D. | +12

CommentIn: Nat Rev Rheumatol. 2022 Mar;18(3):126. - PMID 35110747

4

Doses of rituximab for retreatment in rheumatoid arthritis : influence on maintenance and risk of serious infection

enthalten in: Rheumatology (Oxford, England) | 2018

von Henry, J. | Gottenberg, J. | Rouanet, S. | +7

5

Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes : Data From a Large Therapeutic Trial

enthalten in: Arthritis care & research | 2017

von Cornec, D. | Devauchelle-Pensec, V. | Mariette, X. | +19

6

Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis

enthalten in: The New England journal of medicine | 2014

von Guillevin, L. | Pagnoux, C. | Karras, A. | +66

CommentIn: N Engl J Med. 2014 Nov 6;371(19):1839-40. - PMID 25372093

7

Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome

enthalten in: Annals of the rheumatic diseases | 2007

von Seror, R. | Sordet, C. | Guillevin, L. | +9

1
[1]